Pivot Park Screening Centre (PPSC) is your optimal partner in early drug discovery. At PPSC we provide drug discovery services in the fields of assay development, lab automation, Ultra-High-Throughput Screening (uHTS) and hit-to-lead biological profiling, in order to find novel leads for drug development.
We are continuously expanding our early drug discovery know-how, compound library and services to add value to our vibrant client network and the pharmaceutical R&D community. Through this we help you accelerate drug discovery for a healthier society.
PPSC is located at Pivot Park in the Netherlands, which focuses on pharmaceutical R&D. It is an inspiring campus for open innovation in life sciences.
✔ Integrated approach for early drug discovery
✔ Handling of large customer compound libraries
✔ Big pharma-like uHTS set-up and top-notch read-out technologies
✔ Very experienced screening site for ELF & pharma-accounts
✔ Broad knowledge in different assay development-solutions
✔ From disease targets to high-quality starting points for drug development
Interested? Get in touch and we’ll help you accelerate your drug discovery.
Developing the perfect high throughput biophysical assay using MS
Sometime ago I was inspired by a publication from Simon et al. (SLAS Discovery, 2020)* about possibilities to develop a
Growth Fund invests 325 million euros in Oncode-PACT to accelerate the development of cancer drugs
Utrecht, 14 April 2022 – The National Growth Fund invests 325 million euros in the Oncode-PACT plan to accelerate the preclinical
Malaria is a deadly disease, that affected over 240 million people in 2020, an increase over progress in previous years. Despite advances in malariology, the challenge of finding the right drugs to treat the illness is complex. Find out more about malaria drug discovery in this webinar.
Discovery US 2022 in Boston, November 17-18
Join us at Discovery US and network with us and over 350 industry leaders. We will be there to discuss the latest advancements in ultra-High Throughput Screening, Mass Spectrometry, target identification, validation and HIT optimisation.
Is your assay amendable to ultra-High-Throughput Screening?
Seven aspects to consider…
Subscribe to our newsletter
Pivot Park – Banting Building (RE2423)
Kloosterstraat 9
5349 AB Oss
The Netherlands
Pivot Park Screening Centre
Building OP
Kloosterstraat 9
5349 AB Oss
The Netherlands
To download this publication we would like to receive your e-mail.
To download this publication we would like to receive your e-mail.
To download this publication we would like to receive your e-mail.
